European Union - English - EMA (European Medicines Agency)

csl behring gmbh - alpha1-proteinase inhibitor (human) - genetic diseases, inborn, lung diseases - antihemorrhagics, - respreeza is indicated for maintenance treatment, to slow the progression of emphysema in adults with documented severe alpha1-proteinase inhibitor deficiency (e.g. genotypes pizz, piz(null), pi(null,null), pisz). patients are to be under optimal pharmacologic and non-pharmacologic treatment and show evidence of progressive lung disease (e.g. lower forced expiratory volume per second (fev1) predicted, impaired walking capacity or increased number of exacerbations) as evaluated by a healthcare professional experienced in the treatment of alpha1-proteinase inhibitor deficiency.,

European Union - English - EMA (European Medicines Agency)

csl behring gmbh - alpha1-proteinase inhibitor (human) - genetic diseases, inborn, lung diseases - antihemorrhagics, - respreeza is indicated for maintenance treatment, to slow the progression of emphysema in adults with documented severe alpha1-proteinase inhibitor deficiency (e.g. genotypes pizz, piz(null), pi(null,null), pisz). patients are to be under optimal pharmacologic and non-pharmacologic treatment and show evidence of progressive lung disease (e.g. lower forced expiratory volume per second (fev1) predicted, impaired walking capacity or increased number of exacerbations) as evaluated by a healthcare professional experienced in the treatment of alpha1-proteinase inhibitor deficiency.,

Canada - English - Health Canada

csl behring canada inc - alpha1-proteinase inhibitor (human) - kit - 1000mg - alpha1-proteinase inhibitor (human) 1000mg - enzymes

Canada - English - Health Canada

csl behring canada inc - alpha1-proteinase inhibitor (human) - kit - 4000mg - alpha1-proteinase inhibitor (human) 4000mg - enzymes

Canada - English - Health Canada

csl behring canada inc - alpha1-proteinase inhibitor (human) - kit - 5000mg - alpha1-proteinase inhibitor (human) 5000mg - enzymes

Ireland - English - HPRA (Health Products Regulatory Authority)

grifols deutschland gmbh - human alpha1-proteinase inhibitor - powder and solvent for solution for infusion - alfa1 antitrypsin

Ireland - English - HPRA (Health Products Regulatory Authority)

grifols deutschland gmbh - human alpha1-proteinase inhibitor - powder and solvent for solution for infusion - alfa1 antitrypsin

Ireland - English - HPRA (Health Products Regulatory Authority)

grifols deutschland gmbh - alpha-1-proteinase inhibitor - powder and solvent for solution for infusion - 1000 milligram(s) - proteinase inhibitors; alfa1 antitrypsin

Canada - English - Health Canada

cutter biological, division of miles lab inc. - alpha1-proteinase inhibitor (human) - powder for solution - 25mg - alpha1-proteinase inhibitor (human) 25mg - enzymes

Canada - English - Health Canada

grifols therapeutics llc - alpha1-proteinase inhibitor (human) - powder for solution - 1000mg - alpha1-proteinase inhibitor (human) 1000mg - enzymes